2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…2021 American Transplant Congress
Liver Transplantation with Super Obese Donors (BMI≥50) Grafts: An Acceptable Pathway to Expand the Donor Pool. Analysis of the OPTN/UNOS Liver Transplant Registry
*Purpose: We aimed to analyze the impact of donor body mass index (BMI) on recipient morbidity and survival following liver transplantation (LT).*Methods: The UNOS-STAR database…2021 American Transplant Congress
Center Cost is Not a Barrier to Aggressive Utilization of DCD Livers
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Only 7% of livers transplanted in 2018 were from deceased from cardiac death (DCD) donors and only a minority of transplant centers aggressively utilize…2021 American Transplant Congress
Variation of Liver and Kidney Transplant Practice and Outcomes During Public Holidays in the United States
Transplant surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The outcomes of liver transplant (LT) and kidney transplant (KT) have been shown to be unaffected by the time of transplant surgery whether done…2021 American Transplant Congress
The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients
*Purpose: Simultaneous portal vein thrombosis (PVT) and renal dysfunction (RD) have unknown effects after liver transplant (LT). We analyzed the outcomes of patients with simultaneous…2021 American Transplant Congress
Analyzing the Impact of Covid-19 in the Hospitalized Cohort of Liver Transplant Recipients: An Early Systematic Review and Meta-Analysis
1University of Chicago, Chicago, IL, 2Imperial College, London, United Kingdom
*Purpose: To determine pooled prevalence of outcomes among hospitalized liver transplant recipients with COVID-19 through meta-analysis.*Methods: A database search was completed between Dec1, 2019-Nov15, 2020,…2021 American Transplant Congress
Neutrophil CEACAM1 Induces Hepatic Autophagy and Shapes Innate-adaptive Immune Response in Liver Transplantation: From Mouse-to-human
1Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA, 2Surgery, Kyoto University, Kyoto, Japan
*Purpose: Although CEACAM1 (CC1; carcinoembryonic antigen-related cell adhesion molecule 1; CD66a) regulates innate-adaptive immunity, its role in orthotopic liver transplantation (OLT) remains unknown. CC1 expresses…2021 American Transplant Congress
Neutrophil Extracellular Trap-induced Thrombotic Microangiopathy in Steatotic Mouse Recipients Impacts Liver Transplant Outcomes
UCLA Medical Center, Los Angeles, CA
*Purpose: Nonalcoholic steatohepatitis (NASH) is an emerging global epidemic projected to become the leading indication for liver transplantation (LT). Although recent studies focus on the…2021 American Transplant Congress
Cardiac Risk Assessment in Liver Transplant Candidates: Survey of National Practice Patterns
*Purpose: Cardiac disease is a leading cause of morbidity and mortality in the first year after liver transplantation (LT) and pre-transplant identification is vital to…2021 American Transplant Congress
Impact of Graft Quality on Patient Survival in Sick Patients
*Purpose: It is widely accepted in the literature that patients who have a Model for End Stage Liver Disease (MELD) Score greater than 30 incur…
- 1
- 2
- 3
- …
- 158
- Next Page »